Enstilar® Plaque Psoriasis foam treatment
with the proven efficacy of Enstilar®

See How The Picture Changes

You will be able to see how well your Enstilar® treatment is working by looking for changes in your symptoms over time. Be sure to discuss your treatment outcomes with a qualified healthcare professional.

Are You Ready?

Now is a great time to take the next step.

The good news is that there are many different resources to help you get started with Enstilar®.

Helpful Resources

These photos are actual patient images from Enstilar® clinical trials. They show patients' conditions before treatment and then at Week 1 and Week 4 of therapy.



Week 1

Week 4



Week 1

Week 4

A randomized clinical trial with 426 patients investigated the effectiveness of Enstilar® spray foam or the vehicle alone for the treatment of psoriasis vulgaris on the trunk and/or limbs. Efficacy was assessed using a 5-point IGA at Week 4, with treatment success defined as the percentage of patients who achieved at least a 2-step improvement to reach “Clear” or “Almost Clear” disease severity. Patients with “Mild” disease were required to be “Clear” to be considered a treatment success.(1, 8)

is different.

Learn Why

Two Powerful
One Effective

Learn More

Get Your Co-pay Card

Certain restrictions apply. This card may reduce out-of-pocket expenses. Must be 18 years of age or older to be eligible. You are not eligible if you are enrolled or you participate in any state or federally funded health care program (eg, Medicare, Medicaid, etc). For eligibility requirements and restrictions, see here.

See Terms

Enstilar® Foam is for use on skin only (topical). Do not get Enstilar® Foam in your mouth, eyes, or vagina. Avoid using Enstilar® Foam on your face, groin, or under your arms, or if you have thinning of your skin (atrophy) at the treatment site.

Enstilar® Foam is easily set on fire; avoid heat, flame, or smoking during and right after applying this medication.

Enstilar® Foam may cause serious side effects including too much calcium in your blood or urine and/or adrenal gland problems. You may experience skin problems including allergic reactions. If you get Enstilar® Foam in the mouth or in the eyes, wash the area with water right away. Wash your hands after using Enstilar® Foam unless you are using the medicine to treat your hands. Do not bandage or cover the treated skin area, unless instructed by your doctor.

The most common side effects include irritation, itching, inflammation, changes in skin color, rash, and worsening of your psoriasis. Tell your doctor if you have a calcium metabolism disorder, have thinning-skin (atrophy) at the site to be treated, are getting light therapy (phototherapy treatments) for your psoriasis, are pregnant or plan to become pregnant, or are breastfeeding or plan to breastfeed. Do not use Enstilar® Foam on your breast if you breastfeed. Tell your doctor about all the medicines you take, including prescription and nonprescription medicines, vitamins and herbal supplements. Be sure to tell your doctor if you use other corticosteroid medicines and/or other medicines for your psoriasis. Avoid spending a long time in the sunlight and avoid tanning booths and sun lamps.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Enstilar® (calcipotriene and betamethasone dipropionate) Foam is a prescription medicine used on the skin to treat plaque psoriasis in adult patients 18 years of age and older.

Apply Enstilar® Foam to the affected areas of your skin 1 time a day for up to 4 weeks. You should stop treatment when your plaque psoriasis is under control, unless your doctor gives you other instructions. Do not use more than 60 grams of Enstilar® Foam every 4 days. Use Enstilar® Foam exactly as your doctor tells you to use it.

Please click here for Enstilar® Full Prescribing Information.

Reference: 1. Enstilar® [prescribing information]. Madison, NJ